New Zealand markets closed

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
68.84+0.27 (+0.39%)
At close: 04:00PM EST
67.25 -1.59 (-2.31%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 88.12B
Enterprise value 110.07B
Trailing P/E 11.97
Forward P/E 9.92
PEG ratio (5-yr expected) 0.52
Price/sales (ttm)3.24
Price/book (mrq)4.10
Enterprise value/revenue 4.01
Enterprise value/EBITDA 8.95

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 34.72%
S&P500 52-week change 317.58%
52-week high 374.12
52-week low 361.39
50-day moving average 370.54
200-day moving average 368.90

Share statistics

Avg vol (3-month) 37.62M
Avg vol (10-day) 39.51M
Shares outstanding 51.25B
Implied shares outstanding 6N/A
Float 81.25B
% held by insiders 10.10%
% held by institutions 182.42%
Shares short (30 Dec 2021) 421.3M
Short ratio (30 Dec 2021) 42.91
Short % of float (30 Dec 2021) 41.70%
Short % of shares outstanding (30 Dec 2021) 41.70%
Shares short (prior month 29 Nov 2021) 421.89M

Dividends & splits

Forward annual dividend rate 42.84
Forward annual dividend yield 44.13%
Trailing annual dividend rate 32.81
Trailing annual dividend yield 34.10%
5-year average dividend yield 43.47
Payout ratio 447.87%
Dividend date 329 Dec 2021
Ex-dividend date 413 Dec 2021
Last split factor 22:1
Last split date 327 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 26.91%
Operating margin (ttm)47.25%

Management effectiveness

Return on assets (ttm)12.68%
Return on equity (ttm)37.85%

Income statement

Revenue (ttm)27.48B
Revenue per share (ttm)21.88
Quarterly revenue growth (yoy)12.80%
Gross profit (ttm)21B
Net income avi to common (ttm)7.39B
Diluted EPS (ttm)5.84
Quarterly earnings growth (yoy)620.00%

Balance sheet

Total cash (mrq)6.61B
Total cash per share (mrq)5.27
Total debt (mrq)27.69B
Total debt/equity (mrq)128.95
Current ratio (mrq)1.37
Book value per share (mrq)17.11

Cash flow statement

Operating cash flow (ttm)10.09B
Levered free cash flow (ttm)8.19B